Investor Overview

MGI targets durable margins through IP‑backed products and brand distribution. We provide detailed financial models, phased rollout plans, and clear impact metrics.

 

Market Opportunity – Size & Growth

The global moringa market exceeds USD $9 billion (2025) with an estimated 9–10% CAGR, driven by consumer demand for plant-based nutrition, clean-label ingredients, and sustainable agriculture inputs.

MGI sits at the intersection of these trends, with science-backed products targeting health, functional foods, cosmetics, and agritech categories.

Competitive Edge – Why MGI Wins

• World-class scientific leadership: Three moringa PhD experts (Dr. Chimuka, Dr. Kwaambwa, Dr. Mowa) + a commercialization-focused CEO (Alex Kalambata, MBA).

• IP & know-how: Proprietary extraction and formulation methods aimed at superior efficacy and stability.

• Integrated value chain: From farming partners to finished goods—traceability, quality control, and better unit economics.

• Global route-to-market: Zambia operations with planned distribution in South Africa, Namibia and export partners across the Middle East, Europe, and Asia.

Financial Highlights – Stage & Ambition

• Stage: Pre-seed

• Current pre-seed valuation: USD $3 million

• 10-year company growth goal: USD $500 million

• Capital efficiency: Regional sourcing, scalable processes, and partnership-led GTM to keep CAPEX lean.

• Revenue drivers: Nutraceuticals, agricultural biostimulants, moringa oil, leaf powder, and specialty extracts.

Positioning line: “MGI — where moringa science meets global markets.”

Investor contact: invest@moringagi.com


Download Investor / Media Kit